{
    "nct_id": "NCT02015923",
    "official_title": "Multicenter Randomized Study in Patients With Colorectal Cancer With Unresectable Metastases. Impact of Resection vs no Resection of the Primary Tumour as a Survival Factor",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* colorectal cancer above to 12 cm from the anal verge\n* unresectable synchronous metastases\n* no contraindications for chemotherapy\n* absence of peritoneal carcinomatosis, central nervous system o bone metastasis.\n* performance status ECOG ≤ 2 (Eastern Cooperative Oncology Group)\n* uncontrolled concomitant medical conditions that may compromise to chemotherapy\n* significant symptomatic cardiac disease\n* not pregnancy or breastfeeding\n\nExclusion Criteria:\n\n* Cases of rectal tumours below 12cm from anal verge, or locally advanced tumours invading blood vessels, nerves or bone.\n* Multiple bone metastasis or central nervous system metastasis\n* Other neoplastic disease in the 5 previous years, except squamous or basal cell skin carcinoma or cervical \"in situ\" carcinoma\n* Significant heart disease (chronic congestive heart failure, symptomatic coronary disease) or myocardial infarction in the previous 6 months\n* Peripheral neuropathy\n* Patients who do not give informed consent\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* colorectal cancer above to 12 cm from the anal verge\n* unresectable synchronous metastases\n* no contraindications for chemotherapy\n* absence of peritoneal carcinomatosis, central nervous system o bone metastasis.\n* performance status ECOG ≤ 2 (Eastern Cooperative Oncology Group)\n* uncontrolled concomitant medical conditions that may compromise to chemotherapy\n* significant symptomatic cardiac disease\n* not pregnancy or breastfeeding",
        "exclusion": "* Cases of rectal tumours below 12cm from anal verge, or locally advanced tumours invading blood vessels, nerves or bone.\n* Multiple bone metastasis or central nervous system metastasis\n* Other neoplastic disease in the 5 previous years, except squamous or basal cell skin carcinoma or cervical \"in situ\" carcinoma\n* Significant heart disease (chronic congestive heart failure, symptomatic coronary disease) or myocardial infarction in the previous 6 months\n* Peripheral neuropathy\n* Patients who do not give informed consent"
    }
}